Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Aptevo Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q3 2021
- Shares held
- 760.9K
- −1.96M (−72.1%) vs. Q3 2021
- Total value
- $5.99M
- −$36.1M (−85.8%) vs. Q3 2021
- New holders
- 5
- 3 more added
- Sold out
- 8
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $224.3K |
| Q1 2026 | 9 | $229.7K |
| Q4 2025 | 11 | $191.4K |
| Q3 2025 | 12 | $717.1K |
| Q2 2025 | 7 | $45.9K |
| Q1 2025 | 8 | $22.8K |
| Q4 2024 | 13 | $208.7K |
| Q3 2024 | 19 | $231.1K |
| Q2 2024 | 18 | $599.1K |
| Q1 2024 | 10 | $12.4K |
| Q4 2023 | 29 | $349.7K |
| Q3 2023 | 26 | $1.13M |
| Q2 2023 | 23 | $1.36M |
| Q1 2023 | 24 | $1.82M |
| Q4 2022 | 27 | $2.27M |
| Q3 2022 | 27 | $2.63M |
| Q2 2022 | 27 | $2.85M |
| Q1 2022 | 24 | $4.76M |
| Q4 2021 | 23 | $5.99M |
| Q3 2021 | 26 | $42.1M |
| Q2 2021 | 29 | $65.5M |
| Q1 2021 | 34 | $89.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Aptevo Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6 | $0 | 0.00% | −23−79.3% | Reduced |
| Citigroup Inc | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Earnest Partners LLC | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $0 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 142 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 95 | $1.00K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 291 | $2.00K | 0.00% | 00.0% | Unchanged |
| Total Clarity Wealth Management, Inc. | 500 | $4.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 1,555 | $12.0K | 0.00% | +3+0.2% | Added |
| ACT Capital Management, LLC | 1,500 | $12.0K | 0.01% | +1,500 | New |
| Royal Bank of Canada | 1,614 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,212 | $25.0K | 0.00% | +3,212 | New |
| State Street Corp | 10,973 | $86.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 15,650 | $123.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 22,564 | $178.0K | 0.00% | −187−0.8% | Reduced |
| Geode Capital Management, LLC | 39,807 | $313.0K | 0.00% | −117−0.3% | Reduced |
| Price T Rowe Associates Inc | 46,200 | $364.0K | 0.00% | +46,200 | New |
| BlackRock Inc. | 54,673 | $430.0K | 0.00% | −721−1.3% | Reduced |
| Renaissance Technologies LLC | 68,686 | $541.0K | 0.00% | −74,733−52.1% | Reduced |
| Morgan Stanley | 112,155 | $883.0K | 0.00% | +101,127+917.0% | Added |
| Schonfeld Strategic Advisors LLC | 156,700 | $1.23M | 0.01% | +156,700 | New |
| Vanguard Group Inc | 224,482 | $1.77M | 0.00% | +89,210+65.9% | Added |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,760,000−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −281,402−100.0% | Sold out |
| Towercrest Capital Management | 0 | $0 | 0.00% | −211,227−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −15,350−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,651−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −3,907−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,194−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −218−100.0% | Sold out |